Minnesota Spinoff Readies Clinical Trial for Promising Brain Cancer Drug Therapy
from Twin Cities Business
A newly formed biotech company spun off from University of Minnesota anticancer research says it is wrapping up a Series A funding round and readying initial clinical trials for a potentially game-changing product for fighting brain cancer with immunological drugs.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063